Mostrar el registro sencillo del ítem
dc.contributor.author | Dinger, Bruce | |
dc.contributor.author | González, Constancio | |
dc.contributor.author | Yoshizaki, Katsuaki | |
dc.contributor.author | Fidone, Salvatore | |
dc.date.accessioned | 2014-10-24T07:41:53Z | |
dc.date.available | 2014-10-24T07:41:53Z | |
dc.date.issued | 1981 | |
dc.identifier.citation | Neuroscience Letters, 1981, 21, p. 51-55 | es |
dc.identifier.issn | 0304-3940 | es |
dc.identifier.uri | http://uvadoc.uva.es/handle/10324/6719 | |
dc.description | Producción Científica | es |
dc.description.abstract | Specific dopamine receptors were studied in freshly dissected, unhomogenized rabbit carotid bodies incubated in [3H]spiroperidol. Total binding and non-specific binding were determined in the absence and presence of 0.2 #M (+)-butaclamol, respectively. Specific binding in normal carotid bodies incubated at near saturating concentrations (0.38 nM) was 1.63 _+ 0.58 pmol/g of tissue. Chronic section of the carotid sinus nerve (14 days) resulted in a 64070 reduction (P < 0.05) in specific binding. We conclude that the majority of specific dopaminergic receptors are located on carotid sinus nerve afferent terminals. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Elsevier | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Cuerpo carótido | es |
dc.title | [3H]Spiroperidol binding in normal and denervated carotid bodies | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.publicationfirstpage | 51 | es |
dc.identifier.publicationlastpage | 55 | es |
dc.identifier.publicationtitle | Neuroscience Letters | es |
dc.identifier.publicationvolume | 21 | es |
dc.peerreviewed | SI | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International